Option Care Health, Inc. (NASDAQ:OPCH) Shares Purchased by International Assets Investment Management LLC

International Assets Investment Management LLC boosted its holdings in shares of Option Care Health, Inc. (NASDAQ:OPCH) by 3,029.7% during the 3rd quarter, HoldingsChannel reports. The institutional investor owned 2,848 shares of the company’s stock after buying an additional 2,757 shares during the quarter. International Assets Investment Management LLC’s holdings in Option Care Health were worth $91,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. UMB Bank n.a. grew its stake in shares of Option Care Health by 937.5% during the third quarter. UMB Bank n.a. now owns 830 shares of the company’s stock worth $26,000 after acquiring an additional 750 shares during the last quarter. GAMMA Investing LLC grew its position in Option Care Health by 110.6% during the 3rd quarter. GAMMA Investing LLC now owns 897 shares of the company’s stock worth $28,000 after purchasing an additional 471 shares during the last quarter. Whittier Trust Co. of Nevada Inc. grew its position in Option Care Health by 3,362.8% during the 3rd quarter. Whittier Trust Co. of Nevada Inc. now owns 1,489 shares of the company’s stock worth $47,000 after purchasing an additional 1,446 shares during the last quarter. Blue Trust Inc. increased its stake in Option Care Health by 14.8% during the 2nd quarter. Blue Trust Inc. now owns 2,931 shares of the company’s stock valued at $81,000 after purchasing an additional 377 shares in the last quarter. Finally, SageView Advisory Group LLC purchased a new position in shares of Option Care Health in the first quarter worth $85,000. 98.05% of the stock is currently owned by hedge funds and other institutional investors.

Insiders Place Their Bets

In related news, Director Elizabeth Quadros Betten sold 47,531 shares of the business’s stock in a transaction on Wednesday, August 21st. The shares were sold at an average price of $31.09, for a total value of $1,477,738.79. Following the completion of the transaction, the director now directly owns 21,339 shares in the company, valued at $663,429.51. The trade was a 0.00 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. In other news, Director Elizabeth Quadros Betten sold 47,531 shares of the firm’s stock in a transaction dated Wednesday, August 21st. The stock was sold at an average price of $31.09, for a total transaction of $1,477,738.79. Following the sale, the director now directly owns 21,339 shares in the company, valued at $663,429.51. This trade represents a 0.00 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, CFO Michael H. Shapiro sold 23,217 shares of the company’s stock in a transaction dated Thursday, August 22nd. The stock was sold at an average price of $30.95, for a total value of $718,566.15. Following the completion of the transaction, the chief financial officer now directly owns 247,317 shares of the company’s stock, valued at $7,654,461.15. The trade was a 0.00 % decrease in their position. The disclosure for this sale can be found here. Insiders own 0.64% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of equities research analysts have recently weighed in on OPCH shares. Bank of America lowered shares of Option Care Health from a “buy” rating to a “neutral” rating and dropped their price objective for the company from $43.00 to $29.00 in a report on Wednesday, October 30th. The Goldman Sachs Group lowered Option Care Health from a “buy” rating to a “neutral” rating and cut their price objective for the company from $38.00 to $27.00 in a report on Monday. Jefferies Financial Group downgraded Option Care Health from a “buy” rating to a “hold” rating and decreased their target price for the stock from $38.00 to $26.00 in a report on Thursday, October 31st. Truist Financial cut their price target on shares of Option Care Health from $41.00 to $34.00 and set a “buy” rating on the stock in a report on Friday, November 1st. Finally, Barrington Research decreased their price objective on shares of Option Care Health from $40.00 to $32.00 and set an “outperform” rating for the company in a research note on Thursday, October 31st. Three research analysts have rated the stock with a hold rating and three have issued a buy rating to the company. According to MarketBeat, the company has an average rating of “Moderate Buy” and an average price target of $30.83.

Option Care Health Stock Down 2.4 %

Option Care Health stock opened at $22.93 on Friday. The business’s 50-day moving average price is $29.98 and its 200 day moving average price is $29.74. The company has a quick ratio of 1.32, a current ratio of 1.73 and a debt-to-equity ratio of 0.77. The firm has a market cap of $3.90 billion, a price-to-earnings ratio of 19.23, a price-to-earnings-growth ratio of 2.33 and a beta of 1.32. Option Care Health, Inc. has a 52 week low of $22.25 and a 52 week high of $34.63.

Option Care Health Company Profile

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn’s disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.